Literature DB >> 9441091

The annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901.

E Vynnycky1, P E Fine.   

Abstract

SETTING: England and Wales.
OBJECTIVE: To estimate the magnitude and trend in the annual risk of infection with Mycobacterium tuberculosis in England and Wales since 1901.
DESIGN: Estimates for the prechemotherapy era are derived assuming that 1% of new infections among 0-4 year olds led to fatal tuberculosis meningitis, as found in the Netherlands. The estimates are validated against data from the 1949-1950 national tuberculin survey. We explore the trend thereafter using tuberculous meningitis notifications and data from the 1971-1973 national tuberculin survey, and discuss the utility of data collected under the national bacille Calmette-Guérin (BCG) vaccination scheme for estimating the annual risk of infection.
RESULTS: Tuberculosis meningitis mortality rates among 0-4 year olds declined at 4% per annum until 1950, and suggest that the annual risk of infection declined from 12% in 1901 to 1.9% in 1949. The decline in the annual risk of infection probably accelerated in 1950, although its magnitude cannot be determined accurately.
CONCLUSION: An accelerated decline in the annual risk of infection in England and Wales from 1950 probably resulted from the introduction of chemotherapy, which dramatically reduced the prevalence of sources of infection in the population. Data collected during the national BCG vaccination scheme were found to be unsuitable for estimating infection risks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441091

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  22 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease.

Authors:  E Vynnycky; M W Borgdorff; C C Leung; C M Tam; P E M Fine
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

3.  Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.

Authors:  Sourya Shrestha; Susmita Chatterjee; Krishna D Rao; David W Dowdy
Journal:  J R Soc Interface       Date:  2016-03       Impact factor: 4.118

4.  Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.

Authors:  Laith J Abu-Raddad; Lorenzo Sabatelli; Jerusha T Achterberg; Jonathan D Sugimoto; Ira M Longini; Christopher Dye; M Elizabeth Halloran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

5.  The dormancy regulator DosR controls ribosome stability in hypoxic mycobacteria.

Authors:  Andrej Trauner; Kathryn E A Lougheed; Mark H Bennett; Suzanne M Hingley-Wilson; Huw D Williams
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

6.  Place-based social contact and mixing: a typology of generic meeting places of relevance for infectious disease transmission.

Authors:  M Strömgren; E Holm; Ö Dahlström; J Ekberg; H Eriksson; A Spreco; T Timpka
Journal:  Epidemiol Infect       Date:  2017-06-19       Impact factor: 4.434

7.  The impact of realistic age structure in simple models of tuberculosis transmission.

Authors:  Ellen Brooks-Pollock; Ted Cohen; Megan Murray
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

8.  High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance study.

Authors:  Timothy S C Hinks; Nimu Varsani; David T Godsiff; Thomas C Bull; Katherine L Nash; Lisa McLuckie; Catherine Maule; Tessa Flower; Anthony Warley
Journal:  BMC Infect Dis       Date:  2012-12-06       Impact factor: 3.090

9.  Racial inequality in the annual risk of Tuberculosis infection in the United States, 1910-1933.

Authors:  J L Zelner; C Muller; J J Feigenbaum
Journal:  Epidemiol Infect       Date:  2017-04-24       Impact factor: 4.434

10.  The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.

Authors:  Michael Clark; D William Cameron
Journal:  BMC Pediatr       Date:  2006-03-03       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.